DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pdtlck/leukemia) has announced the addition of the "Leukemia Partnering 2009-2014" report to their offering.
The Leukemia Partnering 2009-2014 provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of leukemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors leukemia technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in leukemia partnering
Chapter 3 - Leading leukemia deals
Chapter 4 - Dealmaking directory
Chapter 5 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/pdtlck/leukemia